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Abstract
The involvement of DNA damage and repair in aging processes is well established. Aging is an unequivocal risk factor
for chronic neurodegenerative diseases, underscoring the relevance of investigations into the role that DNA alterations
may have in the pathogenesis of these diseases. Consistently, even moderate impairment of DNA repair systems
facilitates the onset of pathological features typical of PD that include derangement of the dopaminergic system,
mitochondrial dysfunction, and alpha-synuclein stress. The latter establishes a connection between reduced DNA
repair capacity and a cardinal feature of PD, alpha-synuclein pathology. It remains to be determined, however, whether
alpha-synuclein stress activates in vivo the canonical signaling cascade associated with DNA damage, which is
centered on the kinase ATM and substrates such as γH2Ax and 53BP1. Addressing these issues would shed light on
age-related mechanisms impinging upon PD pathogenesis and neurodegeneration in particular. We analyzed two
different synucleinopathy PD mouse models based either on intranigral delivery of AAV-expressing human alpha-
synuclein, or intrastriatal injection of human alpha-synuclein pre-formed ﬁbrils. In both cases, we detected a signiﬁcant
increase in γH2AX and 53BP1 foci, and in phospho-ATM immunoreactivity in dopaminergic neurons, which collectively
indicate DNA damage and activation of the DNA damage response. Mechanistic experiments in cell cultures indicate
that activation of the DNA damage response is caused, at least in part, by pro-oxidant species because it is prevented
by exogenous or endogenous antioxidants, which also rescue mitochondrial anomalies caused by proteotoxic alpha-
synuclein. These in vivo and in vitro ﬁndings reveal that the cellular stress mediated by alpha-synuclein—a
pathological hallmark in PD—elicits DNA damage and activates the DNA damage response. The toxic cascade leading
to DNA damage involves oxidant stress and mitochondrial dysfunction The data underscore the importance of DNA
quality control for preservation of neuronal integrity and protection against neurodegenerative processes.
Introduction
Parkinson’s disease (PD) is the second most common
neurodegenerative disorder after Alzheimer’s. PD is
characterized by severe loss of dopaminergic neurons in
the substantia nigra pars compacta (SNpc) and it has
been traditionally considered the prototypical movement
disorder. More recently, however, growing consensus
indicates that PD pathology affects multiple domains and
is not conﬁned to motor function, therefore indicating
that PD is rather a multisystem and complex disorder1.
PD pathogenesis proceeds along converging pathways
that impact fundamental cellular functions such as pro-
tein homeostasis and mitochondrial function, and parti-
cularly accumulation of proteotoxic oligomeric alpha-
synuclein (α-syn) and reduced activity of respiratory
complex I2,3. Consistently, overexpression of α-synuclein,
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intracerebral seeding of proteotoxic α-synuclein pre-
formed ﬁbrils (PFF), and toxicological inhibition of com-
plex I recapitulate PD in laboratory models4–8.
Aging is an unequivocal risk factor for several morbid-
ities, including chronic neurodegenerative diseases and
PD9,10. The causes of age-related deterioration are com-
plex and, while there is large consensus that accumulation
of cellular damage in time is pivotal11, the nature of the
mechanisms of aging that speciﬁcally promotes PD onset
remain unclear. Plausibly, age-related alterations favoring
a diseased state encompass multiple factors that even-
tually synergize to sensitize the organism; among these
elements, defective maintenance of genome integrity and
consequent accumulation of DNA damage may be parti-
cularly relevant. DNA is, in fact, at the highest hierarchical
level of biological information and, once corrupted, may
impact other biomolecules to cause profound and trans-
missible and/or long-lasting consequences. DNA damage,
moreover, may cause persistent anomalies in post-mitotic
and non-replaceable cells such as neurons, unless efﬁcient
repair mechanisms amend the lesions in the double-helix.
Consistently, laboratory models and patients with defects
in certain DNA repair pathways, for instance in
transcription-coupled and nucleotide excision repair
(TCR and NER respectively), display a progeroid pheno-
type in which accelerated aging is paralleled by neurolo-
gical defects12. Importantly, DNA damage impacts
mechanisms that are central to PD pathogenesis, includ-
ing mitochondrial function, redox homeostasis, and pro-
tein quality control13.
Collectively, these elements underscore the relevance of
investigations into the role that DNA alterations may have
in the pathogenesis of these diseases14. We have recently
shown that even moderate impairment of DNA repair
systems - including NER, transcription-coupled repair
(TCR), and double-strand break repair pathways (DSB) -
facilitates the onset of pathological features typical of PD
that include derangement of the dopaminergic system,
mitochondrial dysfunction and complex I activity sup-
pression, and increased alpha-synuclein phosphoryla-
tion13. The latter establishes a connection between
reduced DNA repair capacity and a cardinal feature of PD,
synuclein pathology.
It remains to be determined, however, whether alpha-
synuclein stress activates in vivo the canonical signaling
cascade associated with DNA damage, i.e., the DNA
damage response (DDR), which can be monitored by
following its key players ATM, γH2AX, and 53BP1. The
large kinase ATM is recruited at the site of lesions such as
DSBs to phosphorylate in cis the histone H2AX
(γH2AX)15. γH2AX marks the initiation of a nucleation
process resulting in the formation of characteristic
γH2AX nuclear foci, which leads to additional ATM
recruitment at the damage site, thereby escalating the
kinase activity16. The nucleation process is facilitated by
mediator such as 53BP1, which also forms foci at the site
of damage17–19. In light of the connection between DDR
and senescence20, and more in general between DNA
damage accumulation and aging, addressing whether α-
synuclein-mediated proteotoxicity triggers the DDR may
shed light on age-related, crucial mechanisms impinging
upon PD pathogenesis and more in general on neurode-
generation. We therefore explored DDR activation in two
different synucleinopathy in vivo models of PD and
investigated possible causative mechanisms in vitro.
Materials and Methods
Chemicals
Sodium Nitrite (563218), oligomycin (75351), FCCP
(C2920), rotenone (557368) and antimycin (A8674), N-
acetyl-cysteine (NAC, A7250), were obtained from Sigma-
Aldrich (St. Louis, MO, USA).
Animal care
Animals were kept on a regular diet and housed at the
Animal Resource Center (Erasmus University Medical
Center), which operates in compliance with the “Animal
Welfare Act” of the Dutch government, following the
“Guide for the Care and Use of Laboratory Animals” as its
standard.
In vitro synthesis of α-synuclein pre-formed ﬁbrils (PFF)
α-Synuclein pre-formed ﬁbrils (PFF) have been gener-
ated from human α-synuclein monomer in assembly
buffer (PBS, pH 7.0) according to the manufacturer’s
protocol (Proteos). Brieﬂy, 4 mg of monomeric α-syn were
shacked at 1000 r.p.m. for 7 days at 37 °C. Fibrils were
then aliquoted and stored at −80 °C in single use vials.
The efﬁciency of the ﬁbrillation reaction was veriﬁed with
Thioﬂavin T (25 µM, Sigma, T 3516) ﬂuorimeter.
Stereotaxic injection of AAV particles and α-syn pre-
formed ﬁbrils (PFF)
Recombinant adeno-associated virus (serotype 2 gen-
ome and serotype 6 capsid, AAV) was used to express
human h-α-syn in the mouse substantia nigra. Gene
expression was under the control of a human Synapsin 1
promoter and enhanced using a woodchuck hepatitis
virus post-transcriptional regulatory element (WPRE) and
a polyA signal downstream to the α-syn sequence. AAV
vector production, puriﬁcation, concentration and titra-
tion were performed by Sirion (Martinsried, Germany).
C57BL/6 mice were housed under a 12-h light/12-h
dark cycle with free access to food and water. Surgeries
were performed under isoﬂurane anesthesia using a ste-
reotaxic frame (Stoelting, Ireland). Injections was made at
a rate of 0.4 µl/min using a Hamilton syringe ﬁtted to a
glass capillary. The capillary was left in position for an
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additional 5 min before being retracted. To induce hα-syn
expression, n= 16 mice were injected with 1.5 µL of 8.0 ×
1012 genome copies/mL AAV-α-syn into the right sub-
stantia nigra. Stereotaxic coordinates were 2.3 mm pos-
terior and −1.1 mm lateral to Bregma, and 4.1 mm ventral
to dura mater.
PFF injections were made into the striatum of n= 16
mice. 2.5 µL of sonicated PFF (5 µg) were injected under
isoﬂurane anesthesia at the following coordinates: 0.2 mm
anterior and 2.0 mm lateral to Bregma, and 2.6 mm ven-
tral to the dura mater.
Immunohistochemistry
Immunohistological sections were processed as pre-
viously described21. Brieﬂy, free ﬂoating sections were ﬁrst
incubated in hydrogen peroxide (H2O2, Sigma-Aldrich, St.
Louis, MO, USA) 3% in PBS for 30min to block internal
peroxidases activity, and subsequently in PBS-Triton X-
100 0.2% (PBS-T) and normal horse serum (NHS) 10% for
1 h at RT. Specimens were then incubated for 24 h at 4 °C
with mouse monoclonal anti-Tyrosine hydroxylase
(1:4000, MAB318, Millipore, MA, USA) or with afﬁnity
puriﬁed anti human alpha-synuclein (1:3000, AB5038P,
Millipore,), in PBS-T and 1.5% NHS. After several washes
with PBS-T, sections were incubated with biotinylated
goat anti-rabbit IgG (1:500; BA 1000, Vector Laboratories,
Burlingame, CA, USA), in PBS and 1% NHS for 1 h at RT.
Immuno-complexes were revealed by Vectastain Elite
ABC kit (PK 4000, Vector Laboratories, Burlingame, CA,
USA), using 3,3’-diamino-benzidine (DAB Substrate kit
for Peroxidase, SK 4100, Vector Laboratories, Burlingame,
CA, USA). Finally, sections were dehydrated and mounted
with Eukitt (Kindler GmbH & Co.). Slides were observed
with an Olympus BX 51(Olympus, Parkway Center Valley,
PA, USA) microscope equipped with a Leica DFC 420
camera.
Quantiﬁcation of striatal TH density
Striatal lesion in DAB stained sections was calculated as
the extension of the lesioned area, detected by the absence
of TH staining, and expressed as percentage of TH
immunopositive area measured on the contralateral side
(for the AAV model) or on the PBS control mice (for the
PFF model). A total of 5 sections per animals were
analyzed.
Immunoﬂuorescence
In immunoﬂuorescence experiments, sections were
processed as described in the immunohistochemistry
section with minor modiﬁcations. Floating sections were
incubated overnight at 4 °C with a primary antibodies.
The following antibodies were used: mouse monoclonal
anti-Tyrosine Hydroxylase (1:4000, MAB318, Millipore),
sheep polyclonal anti-Tyrosine Hydroxylase (1:4000;
NB300-110, Novus Biologicals), anti-phospho-α-Syn
(S129; 1:1000; ab59264, Millipore, Germany), anti-
γH2AX (1:1000; 05336, Millipore), anti-phospho ATM
(05–740, 1:1000 Upstate Biotechnology); anti 53BP1
(1:1000, 05726, Millipore); Anti- GFP (1:2000; 290-50,
Abcam).
Sections were rinsed with PBS and then incubated for 2
h at RT in TBS containing 0.4 % Triton X-100, 2% NHS,
Alexa488 conjugated donkey anti-rabbit IgG 1:500 (Invi-
trogen), Alexa594-conjugated donkey anti-mouse IgG
1:500 (Invitrogen), CY3-conjugated anti-sheep IgG (1:500,
Jackson). Image acquisition was performed in a Leica TCS
SP5 confocal microscope. The detection parameters were
set in the control samples and were kept constant across
specimens. Images were analyzed in a semi-automated
fashion using the Metamorph software (Molecular Devi-
ces). The software automatically generated regions of
interest (ROI) on the basis of the signal of the cellular
marker (TH) and of the nuclei. The software quantiﬁed
the number of foci within the regions of interest. Values
are expressed as the ratio of number of cells presenting
more than 5 foci over the total dopaminergic neurons that
have been analyzed. At least 50 cells per case were
analyzed.
Unbiased stereological counts
Unbiased stereological estimation of the total number of
the dopaminergic cells in SNpc was made using the
optical fractionator method22 from the STEREO INVES-
TIGATOR program on a Neurolucida computer-
controlled microscopy system (Microbrightﬁeld Inc.,
Williston, VT, USA). The edges of the SNc in the rostro-
caudal axis were deﬁned at all levels, with reference to a
coronal atlas of the mouse brain23. TH-positive cells in
the SNc of both hemispheres were counted in every three
section, on comparable sections for all the subgroups of
treatment throughout the entire nucleus. Counting
frames (60 × 60 µm) were placed at the intersections of a
grid (frame size 120 × 120 µm) that was randomly placed
over the section. For counting, only those counting frames
in which at least a part of the frame fell within the contour
of the SNpc were used. Only in focus, TH-positive cell
bodies were marked. Guard volumes (3 µm from the top
and 3 µm from the bottom of the section) were excluded
from both surfaces to avoid the problem of lost caps. The
reliability of the estimate was assessed by calculation of
the coefﬁcient of as previously described24.
Cell culture and immunocytochemistry
SH-SY5Y neuroblastoma cells were maintained in
DMEM medium, 10% FCS and 1% pen/strep. For differ-
entiation, cells were seeded at a cell density of 50 × 104 on
coverslip coated with poly-Ornithine (P4957, Sigma) and
laminin (L4544, Sigma) and have been differentiated for
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Fig. 1 (See legend on next page.)
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8 days in DMEM 1% FCS and retinoic acid (10 µM, R2625
Sigma).
Differentiated neurons were incubated with PFF
(1 µg/mL) for 18 h and processed for immunocytochem-
istry. Brieﬂy, cells were ﬁxed in PFA 4% for 20′ and, after
washes in PBS, were blocked in 3% BSA, 0,1% Triton X-
100 and PBS for additional 20'. Cells were then incubated
with an anti-synuclein antibody (1:2000; Ab6162, Abcam),
an anti-γH2AX (1:1000; 05336, Millipore), or an anti
53BP1 (1:1000, 05726 Millipore) for 3 h at room tem-
perature (RT). After 3 washes with PBS, cells were incu-
bated for 1 h with the following secondary antibodies:
Alexa488 conjugated donkey anti-rabbit IgG 1:1000
(Invitrogen), Alexa594-conjugated donkey anti-mouse
IgG 1:1000 (Invitrogen), Cy3-conjugated anti- sheep IgG
(1:1000, Jackson). Image acquisition was performed using
a Zeiss SP5 confocal microscope. The detection para-
meters were set in the control samples and were kept
constant across specimens. Images were analyzed in a
semi-automated manner using the Metamorph software
(Molecular Devices). The software automatically gener-
ated regions of interest (ROI) on the basis of the signal of
the nuclei. The software quantitated the number of foci
within the regions of interest and values are expressed of
number of cells presenting more than 5 foci over the
total dopaminergic neurons that have been analyzed;
a minimum amount of 50 cells per case have been
counted.
Bioenergetics proﬁling
The Seahorse XF24 Extracellular Flux Analyzer (Agilent
Technologies, Santa Clara, Ca, USA) was used to generate
the bioenergetics proﬁles as previously described25. SH-
SY5Y cells were seeded at a density of 6 × 104 cells per
well and allowed to adhere overnight. After adhesion, cells
were treated with NAC (1mM), PFF (10 µg/mL), or
vehicle (PBS) dissolved/diluted in growth medium for 18
h or pre-treated for 48 h with sodium nitrite (10 µM) or
vehicle (PBS) before PFF exposure for 18 h. Media were
refreshed daily. On the experimental day, cells medium
was changed to unbuffered DMEM (XF Assay Medium –
Agilent Technologies, Santa Clara, Ca, USA) supple-
mented with 5 mM glucose and 1mM sodium pyruvate,
and incubated 1 h at 37˚ C in absence of CO2. Medium
and reagents were adjusted to pH 7.4 on the day of the
assay. After four baseline measurements for the oxygen
consumption ratio (OCR), cells were sequentially chal-
lenged with injections of mitochondrial toxins: 0.5 µM
oligomycin (ATP synthase inhibitor), 1 µM FCCP (mito-
chondrial respiration uncoupler), 0.5 µM rotenone
(complex I inhibitor), and 0.5 µM antimycin (complex III
inhibitor).
Statistical analysis
All values are expressed as mean ± s.e.m. Statistical
signiﬁcance was assessed by two sided Student’s t test or
one-way analysis of variance (ANOVA) followed by the
Dunnet’s multiple comparison post hoc test. In all
instances a value of P < 0.05 was considered as a threshold
for statistical signiﬁcance.
Results
Proteotoxic α-syn activates the DNA-damage response
To study DDR activation induced by proteotoxic stress
in vivo, we took advantage of two different synucleino-
pathy mouse models of PD based either on intranigral
delivery of AAV-expressing human α-syn (AAV-syn)26, or
on intrastriatal injection of human α-syn pre-formed
ﬁbrils (PFF)8. Six months after stereotaxic injection, AAV-
syn transduced mice displayed signiﬁcant striatal increase
of human α-syn protein levels in the ipsilateral hemi-
sphere, which was paralleled by a remarkable reduction of
striatal tyrosine hydroxylase (TH) immunoreactivity
(Fig. 1a–c). Increased α-syn was also detected inside
dopaminergic cell bodies in the SNpc (Fig. 1d). As
expected, these alterations were associated with sig-
niﬁcant ipsilateral reduction in nigral dopaminergic cell
bodies, as detected by unbiased stereological counts
(Fig.1e).
Lesion in the dopaminergic system was detected also in
PFF treated mice, 4 months after injection, which showed
reduced striatal TH immunoreactivity (Fig. 1f,g) paralleled
by α-synuclein stress—as evidenced by increased
phospho-synuclein levels (p129-syn) (Fig. 1h)—and
reduced dopaminergic cell bodies in the SNpc (Fig. 1i),
when compared to PBS injected animals. Collectively, and
consistently with the original reports5–8, these elements
indicate successful modeling of dopaminergic pathology
(see ﬁgure on previous page)
Fig. 1 α-Synuclein overexpression or intracerebral seeding impacts the dopaminergic system. a–c Intranigral injection of AAV2/6 serotype
expressing human α-syn (h-syn) results in increased protein expression paralleled by reduction in tyrosine hydroxylase (TH) levels. (d) h-syn is also
expressed in dopaminergic cell bodies (arrows). e Unbiased stereological counts demonstrate a reduction in nigral dopaminergic cell bodies.
f, g Intracranial injection of α-syn pre-formed ﬁbrils (PFF) causes striatal dopaminergic denervation as evidenced by a reduction in TH
immunoreactivity. h Increased levels of ser129-phosphosynuclein in the substantia nigra (arrows) indicate α-syn stress in PFF injected animals.
i Unbiased stereological counts showing a decrease in dopaminergic cell bodies in the substantia nigra. Scale bars: 1 mm in a, b 50 μm in d.
(**p < 0.01; ***p < 0.001; Student’s t test). All bar graphs show mean+ /− s.e.m
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Fig. 2 Activation of the DDR in mice transduced with AAV2/6 h-syn. a h-syn expression increases 53BP1 and γH2AX foci, and ATM
phosphorylation in nigral dopaminergic neurons. b The DDR is not activated by viral delivery of GFP. Scale bar: 50 μm. (**p < 0.01; ***p < 0.001;
Student’s t test). All bar graphs show mean+ /− s.e.m
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in animals transduced with AAV-syn or exposed to pro-
teotoxic α-syn.
When we examined DDR activation in AAV-syn mice,
we detected a signiﬁcant ipsilateral increase in the DDR
markers γH2AX and 53BP1 foci, and phospho-ATM
immunoreactivity (Fig. 2a). To rule out the possibility that
DDR activation under these experimental conditions may
be a mere consequence of non-speciﬁc viral toxicity and/
or non-speciﬁc protein overexpression, a separate group
of animals was injected intrastriatally with AAVs carrying
green ﬂuorescent protein (GFP) rather than human α-syn
DNA. Results showed lack of signiﬁcant changes within
AAV-GFP-transduced neurons, supporting the conclu-
sion that DDR activation is indeed a speciﬁc toxic effect
caused by increased α-syn expression within nigral
dopaminergic cells (Fig. 2b).
DDR hallmarks were detectable also in nigral dopami-
nergic neurons of PFF, but not in vehicle-injected mice
(Fig.3a, b). Altogether, these elements demonstrate a
causative link between α-syn proteotoxicity and DNA
damage in dopaminergic neurons.
Oxidation contributes to DDR activation
To explore the intracellular mechanisms responsible for
DDR activation mediated by proteotoxic α-syn species, we
took advantage of the dopaminergic cell line SH-SY5Y,
which has been used by others and ourselves to explore
selected PD mechanisms in vitro25,27. Given that pro-
oxidant reactive species (RS) are associated with α-syn
proteotoxicity28, have been involved in PD pathogenic
mechanisms29, and are major genotoxic agents30, we
hypothesized that DDR activation might be caused, at
least in part, by excessive oxidation. We therefore eval-
uated the effects of the thiol-based RS scavenger and
antioxidant N-acetylcysteine (NAC) on DDR activation in
differentiated SH-SY5Y cells exposed to PFF. Indeed,
NAC reduced levels in both γ-H2AX and 53BP1 foci
(Fig. 4a, b).
To substantiate these ﬁndings, we used a parallel
strategy relying on endogenous rather than exogenous
antioxidants. We therefore treated cells with the nitric
oxide (NO) donor nitrite, which we have shown to trigger
expression of endogenous antioxidant genes via S-
Fig. 3 Activation of the DDR in mice injected with α-syn PFF in the striatum. Augmented levels 53BP1 and γH2AX foci, and ATM
phosphorylation in dopamine neurons of the substantia nigra. Scale bar: 50 μm. (**p < 0.01; ***p < 0.001; Student’s t test). All bar graphs show
mean+ /− s.e.m
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nitrosation of Keap1 and consequent activation of the
Nrf2 pathway25. We found that administration of nitrite
signiﬁcantly reduced PFF-induced formation of γ-H2AX
foci (Fig. 4c). Collectively, these elements indicate that
pro-oxidants mechanistically participate in DDR activa-
tion induced by proteotoxic α-syn.
DDR-activating oxidation impairs mitochondrial function
Mitochondria are the major intracellular source of RS
and when damaged - for instance at the level of the
electron transport chain - production of pro-oxidants
such as superoxide may increase31. Proteotoxic α-syn may
directly cause mitochondrial dysfunction via physical
interaction with these organelles32. Moreover, defective
DNA repair is sufﬁcient to impact mitochondrial function
in the ventral mesencephalic brain region containing the
SNpc13. On these premises, and given the prominent role
of mitochondrial anomalies in PD29, we explored whether
DDR-activating oxidation caused by α-syn toxicity might
impact on mitochondrial function as well. We therefore
evaluated mitochondrial bioenergetics in SH-SY5Y cells
exposed to PFF and found that proteotoxic stress reduced
both basal respiration, reserve capacity, and rotenone
sensitive respiration, i.e., attributable to complex I
(Fig. 5a). Potentiation of exogenous or endogenous anti-
oxidant defenses by NAC or nitrite supplementation,
which attenuated the DDR, also reversed these defects
(Fig. 5a, b). This last set of experiments therefore sub-
stantiated the nexus between proteotoxicity, oxidative
stress, DNA damage, and mitochondria.
Discussion
α-syn containing Lewy bodies are a neuropathological
hallmark of PD, their distribution correlates with clinical
symptoms33, and aggregated α-synuclein causes dopami-
nergic cell death in laboratory animal models8. The major
risk factor for PD is aging, which has been associated to
the accumulation of macromolecular damage, particularly
in DNA. In fact, accumulation of DNA damage secondary
to defective repair systems causes accelerated aging in
patients and in laboratory animals13. Effective genome
maintenance is essential for proper brain function, as
indicated by neurological defects - also at the dopami-
nergic system level - in organisms with defective repair
Fig. 4 Pro-oxidant species contribute to α-syn-mediated activation of the DDR. a, b Administration of the antioxidant NAC mitigates formation
of PFF-mediated γH2AX and 53BP1 foci in differentiated SH-SY5Y cells. c Administration of the nitric oxide donor nitrite, which activates the
endogenous antioxidant Nrf2 pathway, reduces formation of PFF-mediated γH2AX foci. Scale bars: 50 μm. (*p < 0.05; **p < 0.01; ***p < 0.005; ****p <
0.001; one-way ANOVA followed by Dunnet’s multiple comparison post doc test.) All bar graphs show mean+ /- s.e.m
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mechanisms34,35. On these premises, genomic instability
is considered a hallmark of aging11 and DNA damage has
been recently hypothesized to constitute a unifying ele-
ment across different neurodegenerative disorders14. It is
therefore conceivable that the interplay between a major
pathologic feature of PD and a crucial attribute of aging—
i.e., α-synuclein toxicity and DNA damage—may con-
stitute an important mechanism linking PD to its main
risk factor. However, whether α-synuclein could cause
DNA damage in vivo had not been investigated thus far.
Here we used two different rodent models to show that
synucleinopathy causes upregulation of three different
markers of DNA damage in vivo—γH2AX, 53BP1, and p-
ATM—speciﬁcally in dopaminergic neurons. Mechanistic
experiments in cell cultures show that this effect depends,
at least in part, on ROS production because it is reduced
Fig. 5 Potentiation of exogenous or endogenous antioxidants reverses mitochondrial anomalies induced by PFF in SH-SY5Y cells. a
Representative trace of a microscale oxygraphy experiment. b NAC or c nitrite treatments restore basal and rotenone sensitive respiration, as well as
reserve capacity in SH-SY5Y cells exposed to PFF. (*p < 0.05; **p < 0.01; ***p < 0.005; ****p < 0.001; one-way ANOVA followed by Dunnet’s multiple
comparison post doc test.) Graphs represent mean ± s.e.m
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by the enhancement of exogenous or endogenous anti-
oxidant defenses. Our in vivo results are consistent with
previous in vitro evidence showing that α-synuclein can
cause DNA breaks and that the effect is exacerbated by its
oligomerization or oxidation36. It should be emphasized,
however, that H2AX phosphorylation is not uniquely
associated to DSB and can also occur upon formation of
other types of lesions, for instance single strand breaks37.
This evidence, together with our previous data demon-
strating synucleinopathy in mice with mild NER defect13,
suggests that α-synuclein triggers a broad range of DNA
lesions, rather than a single, speciﬁc type of damage.
Moreover, while our results are speciﬁc for α-syn, it is
plausible that also other proteotoxic species—e.g., amy-
loid-beta—might activate DDR. Other studies to evaluate
this possibility are warranted.
DNA damage may be particularly noxious in post-
mitotic cells; genomic integrity might be particularly
threatened in DA neurons, given their intrinsically oxi-
dized intracellular redox state even in normal physiolo-
gical conditions21,38. Accordingly, several studies at
single-cell level reported increased levels of deletions in
dopaminergic neurons’ mtDNA in PD39,40. Additional
evidence indicates that mtDNA may be particularly sen-
sitive to damage in DA neurons41. While collectively these
elements lend support to a pathogenic role for DNA
damage in PD, nuclear genomic integrity in dopaminergic
neurons—in both the diseased and the healthy aging brain
—has not received equal attention, despite the vast
majority of mitochondrial proteins are encoded by
nuclear DNA. This aspect is particularly relevant in light
of recent ﬁndings from our laboratory showing reduced
DNA repair capacity in peripheral ﬁbroblasts of PD
patients, which in PD could synergize with high oxidation
to activate the pathogenic cascade13. More in general,
mild genomic instability caused by defective NER impacts
on the dopaminergic system, causing alterations that
parallel those observed in PD, and is sufﬁcient to cause
increased oxidation as well as α-synuclein stress, as evi-
denced by increased phosphorylated-synuclein levels in
DA neurons. Besides indicating that aging-related geno-
mic instability predisposes to synucleinopathy, this evi-
dence demonstrated that DNA damage is per se sufﬁcient
to trigger proteotoxicity and is also consistent with other
ﬁndings showing that DNA damage triggers ROS gen-
eration by the NADPH oxidase system via H2AX phos-
phorylation42. An escalating feedback loop mechanism
might be therefore envisioned, in which accumulation of
DNA damage caused by aging and/or defective repair
systems promote α-syn stress—also via abnormal oxida-
tion—which in turn causes further DNA damage (Fig. 6).
In cell cultures exposed to proteotoxic α-synuclein, we
showed that DDR activation is paralleled by perturbation
of mitochondrial function and that both anomalies are
mitigated by potentiation of exogenous or endogenous
antioxidants defenses. This evidence establishes a con-
nection between α-synuclein stress, DDR, oxidation, and
the major intracellular site of RS production, i.e., mito-
chondria, and is consistent with the data showing that α-
syn physically interacts with mitochondria and that such
association culminates in redox alterations32. Mitochon-
dria, however, may not be the sole responsible for DNA-
damaging ROS generation; inﬂammation, which occurs in
α-syn models as well as in PD43,44, and activation of
microglial NADPH oxidase, in particular, are also likely
contributors to DNA damage. Additional sources of DNA
damage may also oxidized lipids such 4-HNE, which
induces the formation of toxic exocyclic adducts45.
Moreover, DNA damage in vivo may be caused by other
reactants than pro-oxidants, for instance the methyl
donor metabolite S-Adenosymethionine, which alkylates
DNA46.
Finally, our work is in line with very recent ﬁndings
showing that ATM activation plays an important role in
preventing protein aggregation47. It is therefore plausible
that DDR activation following α-synuclein stress may be
part of a broader biological cellular reaction to contrast
aggregation.
Collectively, these data underscore the importance of
DNA quality control for preservation of neuronal integrity
and protection against neurodegenerative processes. Age-
related impairments of DNA repair capability could pre-
dispose to toxic/pathological processes associated with
the accumulation and aggregation of speciﬁc proteins -
for instance α-synuclein in PD. A progressive decline of
DNA quality control during aging could therefore be a
crucial mechanism underlying the enhanced neuronal
vulnerability of the older brain and its predisposition to
neurodegenerative diseases.
Fig. 6 Schematic illustrating the proposed model in which
proteotoxic stress and DNA damage accumulation synergize to
trigger an escalating positive feedback loop. α-Synuclein
proteotoxicity impacts genomic integrity, which in turn promotes α-
synuclein stress. α-synuclein-mediated DNA damage involves, but is
not limited to the participation of mitochondrial pro-oxidant species,
and other factors may contribute to α-synuclein-mediated DNA
damage. The mechanisms that cause α-synuclein stress following DNA
damage are unknown.
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